Lightcast Discovery Ltd, an early stage developer of a next-generation microfluidic platform aiming to revolutionise complex cell analysis, today announces that it has raised £1.3 m (USD 1.6m) in seed financing from private investors to develop the capabilities and applications of its platform including continuing to expand its range of pilot studies.
Lightcast Discovery Ltd
Our mission is to push the boundaries of complex cell analysis. Using the Lightcast platform we are working with major pharmaceutical companies and leading academic institutes to enable them to discover more. Together, using our next generation microfluidic platform, we are making advances towards new science, unique clinical approaches, new therapies and innovative products.